C3 Wave App, v. 2.0.5

FDA Device Recall #Z-0222-2020 — Class II — October 1, 2018

Recall Summary

Recall Number Z-0222-2020
Classification Class II — Moderate risk
Date Initiated October 1, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medical Components, Inc dba MedComp
Location Harleysville, PA
Product Type Devices
Quantity 24

Product Description

C3 Wave App, v. 2.0.5

Reason for Recall

When the iPad is updated with Apple iOS software version 12, the C3 application malfunctions. Upon launching a new procedure, the ECG waves do not appear on the screen, in surface or internal mode. If the C3 application is not operating properly, the PICC procedure must be completed without using alternate methods to confirm PICC tip placement.

Distribution Pattern

Distributed to accounts in AZ, CA, CO, FL, IL, LA, MA, ME, NC, OH, TN, VA, and WV. Foreign distribution to Canada, Croatia, Czech Republic, Great Britain, Greece, Italy, Netherlands, Slovenia, and Sweden.

Lot / Code Information

v. 2.0.5; all units

Other Recalls from Medical Components, Inc dba MedComp

Recall # Classification Product Date
Z-1184-2021 Class II Power Injectable CT Port insertion kits - Produ... Jan 13, 2021
Z-2940-2020 Class II Medcomp 15.SF X 24CM Titan HD CATHETER (CUFF 1... Jul 27, 2020
Z-2215-2019 Class II 14F x 20CM SLX Double Lumen Full Tray Hemodialy... Mar 13, 2019
Z-2217-2019 Class II 14F x 30CM SLX Double Lumen Full Tray Hemodialy... Mar 13, 2019
Z-2216-2019 Class II 14F x 24CM SLX Double Lumen Full Tray Hemodialy... Mar 13, 2019

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.